General
Preferred name
RESCINNAMINE
Synonyms
Rescinnamin ()
Rescinnamine ()
Cinnaloid ()
Tsuruselpi s ()
Resealoid ()
Apoterin s ()
Scinnamina ()
NSC-15628 ()
Rescisan ()
Cartric ()
Moderil ()
Cinnasil ()
Reserpinine ()
P&D ID
PD013822
CAS
24815-24-5
Tags
natural product
drug
available
Approved by
FDA
First approval
1956
Drug indication
Hypertension
Drug Status
approved
withdrawn
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Rescinnamine is an angiotensin-converting enzyme (ACE) inhibitor. There is no information regarding approval for clinical use of this drug on the US FDA website. Other national approval agencies may have granted marketing authorisation.
(GtoPdb)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
10
ChEMBL Approved Drugs
ChEMBL Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
NPC Screening Collection
ReFrame library
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
23
Molecular Weight
634.29
Hydrogen Bond Acceptors
10
Hydrogen Bond Donors
1
Rotatable Bonds
9
Ring Count
6
Aromatic Ring Count
3
cLogP
4.57
TPSA
117.78
Fraction CSP3
0.49
Chiral centers
6.0
Largest ring
6.0
QED
0.27
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
ATC
C02AA01
Therapeutic Class
Antihypertensive Agents
Source data
